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a b s t r a c t
We explored the mechanisms underlying microglia cell-carbon nanotube interactions in order to
investigate whether electrical properties of Carbon-Nanotubes (CNTs) could affect microglia brain cells
function and phenotype. We analyzed the effects induced by highly electro-conductive Multi-Walled-
Carbon-Nanotubes (a-MWCNTs), on microglia cells from rat brain cortex and compared the results with
those obtained with as prepared not conductive MWCNTs (MWCNTs) and redox-active Double-Walled-
Carbon-Nanotubes (DWCNTs). Cell viability and CNT capacity to stimulate the release of nitric oxide (NO),
pro-inﬂammatory (IL-1b, TNF-a) and anti-inﬂammatory (IL-10, TGF-b1) cytokines and neurotrophic
factors (mNGF) were assessed.
Electro-conductive MWCNTs, besides not being cytotoxic, were shown to stimulate, at 24 h cell
exposure, classical "M100 microglia activation phenotype, increasing signiﬁcantly the release of the main
pro-inﬂammatory cytokines. Conversely, after 48 h cell exposure, they induced the transition from
classical "M100 to alternative "M200 microglia phenotype, supported by anti-inﬂammatory cytokines and
neuroprotective factor mNGF release. The analysis of cell morphology change, by tubulin and CD-
206 þ labelling showed that M2 phenotype was much more expressed at 48 h in cells exposed to a-
MWCNTs than in untreated cells.
Our data suggest that the intrinsic electrical properties of CNTs could be exploited to modulate
microglia phenotype and function stimulating microglia anti-inﬂammatory potential.
1. Introduction
Beyond their unusual mechanical properties, metallic carbon
nanotubes (CNTs) possess, depending on their structure, a large
electrical conductivity that enables them to conduct low voltage
electrical currents between electrochemical interfaces. It has been
demonstrated that some of the mechanisms modulating their
interactionwith cell membranes reside in their electrical properties
[1,2].
Recent researches in nanotechnologies have increasingly
focused on the exploitation of CNTs as nanotools to be applied in
several areas of nerve tissue engineering to modulate neurobio-
logical processes, such as growth and organization of neural net-
works, in order to accomplish nerve tissue reconstruction and
repair [3]. For instance, it has been recently reported that nano-
tubes can sustain and promote electrical activity in networks of
cultured neurons [4], that functionalized carbon nanotubes (f-
CNTs) induce neurites outgrowth in dorsal root ganglion neurons
[5], and that CNT interfaces enhance neurite outgrowth [6].
Despite CNTs are currently investigated for their beneﬁcial use
in nervous system tissue engineering, the number of studies about
the effects of CNTs on microglia cells, the resident immune cells of
the brain that possess a key role in modulating both CNS injury and
repair, is limited.
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Inﬂammatory responses characterized by pro-inﬂammatory
molecules production, oxidative stress, free radicals production,
peroxidation product accumulation and DNA damages in different
cell types, and among them neural cells, exposed to CNTs have been
reported, but a few data on the interactions between these carbon
nanoparticles and microglia exist [7e17].
The central nervous system (CNS) is composed of a complex
network of neurons and neuroglial cells. The term neuroglia covers
several highly heterogeneous populations of cells that form a
supporting structure for the neurons, providing them with insu-
lation, and regulating brain homeostasis. Recently, the key role
played by glia in the progression and outcome of most neurological
diseases has been highlighted [18,19].
Microglia are considered as the brain's resident immune cells
that, similarly to macrophages, are activated in response to in-
ﬂammatory/immunological stimulations and/or neurological in-
juries [20]. Depending on the phenotype, microglia can produce
either cytotoxic or neuro-protective effects [21]. In the mature
brain, microglia typically exist in a resting state and monitor the
brain environment [22]. In response to brain injury or immuno-
logical stimuli, microglia are readily activated and undergo a
consistent transformation from their ramiﬁed resting state towards
an amoeboid morphology [23]. Classically activated microglia
called “M1” phenotype, are involved in the regulation of brain
development by enforcing, through the production of pro-
inﬂammatory molecules, the programmed elimination of neural
cells [24]. Alternatively activated microglia called “M2” phenotype,
enhance neuronal survival through the release of trophic and anti-
inﬂammatory factors and anti-inﬂammatory cytokines [25]. Be-
sides, “M2” microglia facilitate neuronal repair through the guided
migration of stem cells towards the site of inﬂammation and injury
and could be involved in neurogenesis [26]. In their activated state,
microglial cells react to endogenous or exogenous signals with a
variety of physiological responses [27]. Recent studies have shown
that, in response to certain environmental toxins, endogenous
proteins and bacterial or viral signals microglia can enter in an over
activated state and release neurotoxic and pro-inﬂammatory fac-
tors, including nitric oxide (NO) [28], inﬂammatory cytokines, such
as interleukin-1b (Il-1b), tumor necrosis factor-a (TNF-a), reactive
oxygen species (ROS) [29], and glutamate [30]. Microglia can also
undergo the alternativeM2 phenotype as a consequence of parasite
invasion and in response to endogenous immune signals, in order
to provide tissue repair and resolution of inﬂammation [31].
Recently, emerging lines of evidence indicate that physiological
functions of microglia play a key role in the regulation of CNS ac-
tivity, impact neuronal circuitry and network connectivity, and
contribute to neuronal plasticity [21,28]. Thus, microglial cells can
be considered as dual-functioning cells that are critical in normal as
well as in diseased CNS.
Given the major importance of microglial cells in regulating
brain functions and in view of the potential exploitation of car-
bonebased nanoparticles for neuro-regeneration and neuronal
repair, we aimed to assess the potential of three different CNT types
to modulate the function of microglial cells. At this purpose we
challenged microglia with pristine multi-walled-carbon-nanotubes
(MWCNTs), pristine annealed multi-walled-carbon-nanotubes
with electro-conductive properties (a-MWCNTs) and double-
walled-carbon-nanotubes (DWCNTs). We ﬁrst investigated the
cytotoxic potential of the three CNT samples on microglia cells
isolated from rat brain cortex. Then we assessed microglia pheno-
type changes and measured the main pro-inﬂammatory (TNF-a, IL-
1b), anti-inﬂammatory (IL-10, TGF-b1), neuro-toxic (glutamate)
and neuro-protective (mature Nerve Growth Factor) molecules
secreted by microglia cells at 24 h and 48 h exposure. Cell exposure
was limited to 48 h because a prolonged exposure, being a primary
culture, could have reduced cellular vitality invalidating the results;
furthermore, our aimwas to explore the short term cell response to
CNTs, and especially to electro-conductive a-MWCNTs, due to our
previous ﬁndings showing that CNT electrical properties affect
signiﬁcantly the so called ‘‘charge-sensitive’’ cell parameters and
stimulate the cellular pro-inﬂammatory response in a very short
time [1,2]. The results of the present study showed that only
electro-conductive a-MWCNT, besides not being cytotoxic, were
able to stimulate, at 24 h cell exposure, the classical microglia
activation (M1 phenotype) with production of pro-inﬂammatory
molecules, then to induce, after 48 h exposure, the transition to
M2 phenotype (alternative activation), with production of anti-
inﬂammatory cytokines and of the neurotrophic factor mNGF.
2. Experimental
2.1. Carbon nanotube samples
MWCNTs (CRMD, Orl!eans, France) were synthesized by a regular
catalytic chemical vapor deposition (CCVD) technique, as described
[1]. A full characterization of the two MWCNT samples was previ-
ously assessed (Supplementary Material) [1,2]. The MWCNTs were
used either as prepared and puriﬁed before annealing (MWCNTs),
or after puriﬁcation by annealing at 2400 !C under argon atmo-
sphere (a-MWCNTs). For the in vitro studies, the MWCNT samples
were sterilized by heating at 180 !C, washed three times in distilled
water, then re-suspended in Ca- and Mg-free phosphate buffered
saline (PBS) at a concentration of 1mg/mL. Dispersion was per-
formed through a 48 h gentle sonication in a bath sonicator at the
lowest power and the particles were analyzed and put into the cell
cultures for cell treatment immediately after sonication and vortex
agitation.
The electrochemical experiments performed to investigate the
electrical properties of both MWCNT samples were carried out as
previously described [2]. a-MWCNTs have been shown to exhibit a
much higher electrical conductivity than MWCNTs. Double-walled-
carbon-nanotubes (DWCNTs), synthesized by CCVD as described
earlier [32] have been shown to possess a redox peak, with E1/2
potential, at $70mV, attributable to metallic impurities left over
from the catalyst used in the synthesis [33]. MWCNTs, a-MWCNTs
and DWCNTs characteristics are summarized in Table 1
(Supplementary Material).
2.2. Primary rat microglial cell cultures
All animal related procedures were carried out in accordance
with the directives of the Italian and EU regulations for care and use
of experimental animals (DL116/92) and approved by the Italian
Ministry of Health.
Primary microglial cells were obtained from the cerebral cortex
of 1- or 2-days old rats as previously described. Brieﬂy the cortices
were dissected and cells were dispersed by mechanical and enzy-
matic dissociation using a solution of trypsin and DNase I (Sigma
Chemicals Co., St. Louis, MO, USA) diluted in Caþþ-free Phosphate
Buffer Solution. Cells were plated at a density of 4.4% 104 cells/cm2
in T75 ﬂasks, in D-MEM supplemented with 10% FCS and antibiotics
(100 U/mL of penicillin and 100mg/mL of streptomycin, Invitrogen
Corporation, Carlsbad, CA, USA). The medium was changed after
24 h, then twice a week. After 10e14 days from dissection, micro-
glia was detached from the astrocyte monolayer by shaking and the
cells re-suspended in DMEM/F12 supplemented with 10% FCS and
antibiotics (as above) and seeded in 24multiwell plates at a density
of 5% 105 cells/mL, and incubated at 37 !C in a humidiﬁed atmo-
sphere containing 5% CO2. For confocal microscopy investigations,
puriﬁed microglia was seeded on Lab-Tek™ II 8 wells Chamber
Slide™ (Nunc™, Thermo Scientiﬁc, USA) at a density of
1% 105 cells/mL. Purity of microglial cell populations (>98%) was
veriﬁed by staining with Iba-1 (1:1000) antibody (Wako Pure
Chemical Industries Ltd., Osaka, Japan) (Fig. 1S). Cells were treated
with CNT samples for 24 h up to 48 h at a concentration of 60 mg/
mL. This concentration was selected, based on our previous ex-
periments, as the lowest concentration able to affect the examined
parameters, without inducing excessive cytotoxicity and in order to
avoid the saturation of the response observed with higher doses.
2.3. Cell viability
The CNT effects on the viability and potential toxicity on the
microglial cells were assessed by three experimental approaches.
First of all we evaluated the effect of CNTs on the capacity of cells to
adhere to the culture plate, by measuring the number of cells
attached to the plate after 24 h and 48 h CNT exposure. Then, the
potential toxicity of the different CNTs was investigated by cell
counting using Trypan blue exclusion. For this purpose, cells were
seeded and treated with CNTs (60 mg/mL) in 6 wells plates at a
density of 106 cells/well. The medium was collected after 24 h or
48 h and spun down to recover cells not attached to the bottom of
the dish. Conversely, attached cells were mechanically dislodged
with trypsin. Both cell fractions were counted using an hemocy-
tometer. The statistical deviation was calculated from 3 dishes for
each condition.
Secondly, the same experimental design was repeated, the
medium was removed, cells detached with trypsin and incubated
with Trypan blue. Cell viability was determined after 24 h and 48 h
treatment, based on the Trypan blue exclusion method.
Finally, in order to detect the cytotoxic effect of these CNTs we
evaluated their capacity to induce cell necrosis by using a cyto-
toxicity detection kit for lactate dehydrogenase (LDH, from Roche
Diagnostics, Indianapolis, IN, USA), a classic cell death marker,
whose release indicates the cellular membrane rupture. This assay
was performed in a 96-well microplate, according to the manu-
facturer's recommendations. Brieﬂy, 100% toxicity corresponds to
the total amount of LDH cells can release after solubilization of the
membrane.
2.4. Imaging
2.4.1. Determination of apoptotic cells by TUNEL labelling
Then we investigated, by TUNEL labeling, whether CNTs could
induce another kind of cell death: apoptosis. Indeed, cell death can
occur in various ways (necrosis, apoptosis, autophagy) and for
various causes (physiological or pathological). Apoptosis is a type of
programmed cell death that occurs physiologically and/or patho-
logically in response to different stimuli. For TUNEL labeling,
microglial cells seeded onto 8-wells Lab-Tek™were ﬁxed after 48 h
CNTs exposure with paraformaldehyde 4% in phosphate buffer
(Sigma Chemicals Co., St. Louis, MO, USA) and then permeabilized
brieﬂy with Triton %100. Cells were then labeled with terminal
deoxynucleotidyl transferase (TdT, 40 units) and 5 mM Biotin in
TUNEL Buffer (Roche, Basel, Switzerland) for 1 h at 37 !C as previ-
ously described [34].
Positive cells were detected using Streptavidin Alexa Fluor 647
conjugate (Invitrogen Corporation, Carlsbad, CA, USA, working
dilution 1:200). Positive TUNEL controls were obtained after
exposure of CNT untreated microglia to DNAse (Sigma Chemicals
Co., St. Louis, MO, USA) for 1 h at 37 !C, while negative controls, for
immunoﬂuorescent background determination, were obtained by
omitting the Biotin during TUNEL labeling.
For the quantitative assessment analysis, 300 nuclei/experi-
mental paradigm were counted on random microscope ﬁelds and
results were expressed as percentage of cells exhibiting nuclear
TUNEL labeling.
2.4.2. Determination of autophagosome formation
Furthermore, we evaluated the CNT capacity to induce the third
type of cell death: autophagy, a physiological process that the cells
perform, generally, in the event of nutrient deﬁciency. Autophagy
was evaluated by analyzing the redistribution at level of cyto-
plasmic vacuoles of the autophagy membrane marker LC3. Cells
seeded onto 8-wells Lab-Tek™ and treated with CNTs for 48 h were
ﬁxed and permeabilized as above, then processed for immunoﬂu-
orescent staining using a primary antibody against LC3 (Abcam,
working dilution 1:200 for 1 h at room temperature) revealed using
an Alexa Fluor® 488 anti-rabbit secondary antibody (Invitrogen,
Thermo Fisher Scientiﬁc, working dilution 1:200 for 1 h at room
temperature). Nuclei were counterstained with Hoechst dye.
Cells grown in serum-free medium for 24 h (starvation condi-
tion), were used as positive control of autophagy.
2.4.3. Determination of cell morphology change by tubulin labeling
To assess cell morphology changes after CNT exposure, cells
were seeded, CNTs treated and processed as above, then subjected
to immunoﬂuorescent staining using a primary antibody against
tubulin (Sigma Chemicals Co., St. Louis, MO, USA, working dilution
1:2000 for 1 h at room temperature) and a secondary Alexa Fluor®
488 anti-mouse antibody (Invitrogen, Thermo Fisher Scientiﬁc,
working dilution 1:200 for 1 h at room temperature). Nuclei were
Table 1
Characteristics of CNT samples.
DWCNTsa MWCNTsb
Synthesis/production CCVD CCVD
Catalyst Co/Mo-MgO CoMgO
Chemical composition (wt. %) 92% C
(5% Co, Mo)
MWCNTs (as-prepared):
99% C (Co 0.06 at%; O 0.5 at %)
a-MWCNTs (annealed at
2400 !C):
100% C (O 0.2 at%)
Number of walls/layers
(from HRTEM)
80% DWNTs, 15% SWCNTs, 5% TWCNTs 15
Size Length: 1e10 mm; up to >100 mmwhen in bundles. Diameter 1e3 nm (from TEM) Length:. 1e10 mm
Diameter: 10e15 nm(from TEM)
Experimental Speciﬁc surface area (m2/g) (from BET) 980 240
CCVD: Chemical Catalytic Vapor Deposition.
a E. Flahaut, R. Bacsa, A. Peigney, Ch. Laurent. Gram-Scale CCVD Synthesis of Double-Walled Carbon Nanotubes. Chem Commun 2003; 12: 1442e1443.
b Delpeux S, Szostak K, Frackowiak E, Bonnamy S, B!eguin F. High yield of puremultiwalled carbon nanotubes from the catalytic decomposition of acetylene on in-situ formed
cobalt nanoparticles. J Nanosci Nanotechnol 2002; 2:481e484.
counterstained with Hoechst dye (Sigma Chemicals Co., St. Louis,
MO, USA).
2.4.4. Determination of M1/M2 transition
Cells were treated with CNTs and prepared for immunoﬂuo-
rescence as described above. Antibodies used were:
- Mouse monoclonal anti-CD11b from Abcam, working dilution
1:100
- Rabbit polyclonal anti-mannose receptor (CD206) from Abcam,
working dilution 1:200
- Alexa Fluor® 488 anti-mouse from ThermoFisher Scientiﬁc,
working dilution 1:200
- Alexa Fluor® 594 anti-rabbit from ThermoFisher Scientiﬁc,
working dilution 1:200
All antibodies were incubated for 1 h at room temperature and
nuclei were counterstained with Hoechst dye.
Immuno-labeling general procedure was previously described
[34]. All imaging studies were conducted using a LEICA TCS SP5
confocal microscope (Leica Instruments, Wetzlar, Germany).
For quantitative analysis, for each experimental paradigm at
24 h or at 48 h, 300 CD11b positive cells were counted on randomly
accessed confocal microscope ﬁelds and, among them, the percent
of CD206 positive cells was determined. This analysis was made by
two persons while blinded for the experimental conditions. Results
are expressed as % M2, CD206 positive phenotype among CD11b
positive cells, ± S.D obtained from the two independent readings.
2.5. Western blot (WB) analyses
2.5.1. Analysis of inducible-NOS (i-NOS) and glutamate transporters
(GLAST and GLT-1)
Inducible-Nitric Oxide Synthase (i-NOS) expression was evalu-
ated in microglial cells treated with MWCNTs, a-MWCNTs or
DWCNTs at 60 mg/mL for 24 h; GLAST and GLT-1 glutamate trans-
porter expression was evaluated in microglial cells treated with
DWCNTs at the same concentration.
After CNT treatment, the microglial cells were lysed in ice-cold
lysis buffer (10mM TriseHCl, pH 7.5; 150mM NaCl; 1mM EDTA;
50mM sodium ﬂuoride; 1% Triton X-100; 10% glycerol), supple-
mented with protease and phosphatase inhibitors (1mM sodium
orthovanadate, 1mM phenylmethanesulfonyl ﬂuoride, 25mM
glycerol-2-phosphate, 10 mg/mL aprotinin and 1 mg/mL leupeptin).
Protein concentration of each lysate was determined by Bradford
assay. Equal amounts of proteins were electrophoretically sepa-
rated and transferred onto nitrocellulose membrane. After blocking
of the membranes, primary antibodies for iNOS, GLAST and GLT-1
were incubated at proper dilutions (1:1000 for anti-iNOS, 1:400
for anti-GLAST and 1:500 for anti-GLT-1 all from Santa Cruz, CA,
USA). After washes, the membranes were incubated with an
horseradish peroxidase (HRP)-conjugated anti-rabbit secondary
antibody (1:2500 from Invitrogen Corporation, Carlsbad, CA, USA)
and the immunoreactivity visualized by chemiluminescence (ECL)
(Bio-Rad, Hercules, CA, USA) according to manufacturer's recom-
mendations. Scanning densitometry was performed using the
ImageJ 1.47 program and signal density was normalized to b-actin
signal density. Data are presented as the mean± S.D.
2.5.2. Analysis of LC3 expression and turnover
For LC3 WB analysis, cells were processed as explained above.
Lysosomal turnover of endogenous LC3-II was analyzed in all
samples in absence and in presence of two lysosomal protease in-
hibitors, E64d (10 mg/mL) and Pepsatin A (10 mg/mL) (Applichem
GmbH, Germany). A positive control was prepared by serum
starvation of the cells for 48 h.
Values were normalized to b-actin and were reported as relative
amount of LC3-I and LC3-II in presence of inhibitors (% vs untreated
control) extrapolated from two separated western blot analyses.
Data are presented as the mean± S.D.
2.6. Nitric oxide (NO) production
Nitric Oxide production by microglia exposed to CNTs was
assessed as NO is one of the main markers of microglia “M1” acti-
vation possessing pro-inﬂammatory activity, unlike that one
released by vascular endothelial cells that possess vasodilatation
activity. Nitrite we detected derives from the activity of iNOS.
Microglial cells were exposed for 24 h to 60 mg/mL MWCNTs, a-
MWCNTs or DWCNTs. NO production in microglial culture super-
natants was evaluated by measuring nitrite, a stable end product of
NO. Nitrite was determined by a colorimetric assay with Griess
reagent. One-hundred microliters of culture medium was reacted
with an equal volume of Griess reagent (one part of 1% sulphani-
lamide dissolved in 5% H3PO4 and one part of 0.1% naph-
thylethylenediamine dissolved in distilled water) in 96-well culture
plates for 10min at room temperature. The absorbance was
measured with a microplate reader at 545 nm using a calibration
curve made of sodium nitrite standards (0.7e50 mM).
2.7. ELISA analyses
2.7.1. Cytokines release
Cells were treated with MWCNTs, a-MWCNTs and DWCNTs at
60 mg/mL for 24 h or 48 h. The supernatants were then withdrawn
and pro-inﬂammatory cytokines TNF-a and IL-1b and anti-
inﬂammatory cytokines IL-10 and TGF-b1 were assayed using the
following commercially available kits and following the respective
manufacturer's recommendations:
- TNF-a: ER3TNFA from Thermo Scientiﬁc
- IL-1b: BMS630 from Affymetrix
- TGF-b1: BMS623/3 from Affymetrix
- IL-10: ERIL10 from Thermo Scientiﬁc
All those kits were purchased from ThermoFisher Scientiﬁc
(Waltham, MA, USA). The colorimetric reaction was measured in
absorbance mode using a Victor ELISA reader (PerkinElmer, Milan,
Italy).
2.7.2. Mature nerve growth factor (mNGF) release
Concentration of mNGF was analyzed, in conditioned medium,
using a speciﬁc ELISA developed by Soligo et al. and recently
described [35]. In brief to recognize mNGF, the AF-256-NA capture
antibody (R&D System, Minneapolis, MN, USA) was coated over
night at room temperature. After blocking 1 h at room temperature
with PBSþ1% BSA, samples were incubated for 6 h at room tem-
perature. The microwells were then incubated with 27/21-mNGF
detection antibody (Chemicon MAB5260Z, Merck Millipore,
Vimodrone, MI, Italy) dissolved in blocking buffer overnight at 4 !C.
HRP-conjugated anti-mouse antibody was added and incubated for
2 h at room temperature. To visualize antibody reactivity the
chromogenic substrate 3,30,5,50-tetramethylbenzidine (TMB, Sigma
Chemicals Co., St. Louis, MO, USA) was used and color development
was stopped by adding 1N HCl. The colorimetric reaction was
measured in absorbance mode at 450 nm using a Multiskan EX
ELISA reader (ThermoFisher Scientiﬁc Laboratory Equipment,
Hudson, NH, USA).
2.8. Extracellular and intracellular glutamate determination
Extracellular and intracellular glutamate levels were measured
using a colorimetric glutamate assay kit from Abcam (Cambridge,
UK). As reported for other experiments, microglial cells were
treatedwith DWCNTs, MWCNTs or a-MWCNTs at 60 mg/mL for 24 h.
Culture medium was collected, cells were washed with PBS and
then lysed with 100 ml of ice cold lysis buffer (10mmol/L Tris-HCl
pH 7.5, 150mmol/L NaCl, 1mmol/L EDTA, 50mmol/L sodium ﬂuo-
ride, 1% Triton X-100, 10% glycerol). Glutamate concentrations in
culture medium and in cell lysates were determined according to
the manufacturer's recommendations. The absorbance was
measured with a microplate reader at 450 nm using a calibration
curve of L-glutamate (0e10 nmol).
2.9. Statistical analysis
All analyses were performed in at least three independent ex-
periments. Data were reported as mean± SD. Statistical analysis
was performed using GraphPad Prism Software v.6.00 (GraphPad,
San Diego, California). Signiﬁcance between the groups was
determined using one-way and two-way analysis of variance
(ANOVA) followed by post hoc Bonferroni's multiple comparison
test. Values of p< .05 were considered statistically signiﬁcant.
3. Results
3.1. Effects of CNTs on cell attachment and cell viability
Cell attachment and cell viability in presence of CNTs, assessed
at 24 and 48 h, are summarized in Fig. 1. At 24 h, MWCNTs signiﬁ-
cantly reduced the number of cells attached to the plate and,
conversely, increased the number of not attached cells (Fig. 1a).
Indeed, about 35% of cells exposed to MWCNTs were found not
attached compared to about 15% for cells exposed to a-MWCNTs or
about 17% for DWCNTs and about 5% in control, untreated cells.
At 48 h, the data for MWCNTs were almost similar for attached
cells but no statistically signiﬁcant difference versus control cells
was observed for not attached cells. a-MWCNTs and DWCNTs
treated cultures showed results similar to control for attached cells,
but the number of not attached cells was signiﬁcantly increased
(Fig. 1b).
Trypan blue exclusion based cell counting (Fig. 1c) showed at 24
and 48 h about 90% of living cells in controls (94.21% and 90.00%
respectively). a-MWCNTs and DWCNTs barely reduced cell
viability: 85.00% and 80.86% at 24 and 48 h respectively for a-
MWCNTs and 82.35% and 78.74% at 24 and 48 h respectively for
DWCNT. On the contrary only MWCNTs signiﬁcantly decreased cell
viability as early as after 24 h and up to 48 h (64.88% at 24 h; 64.27%
at 48 h; p< .01 vs CTRL).
Measurement of LDH release in the culture media after 24 h and
48 h exposure to MWCNTs, a-MWCNTs and DWCNTs, showed no
signiﬁcant variationwith respect to control untreated cells (Fig.1d).
3.2. Apoptosis and autophagy
To verify whether CNTs induced programmed cells death, we
analyzed apoptosis and autophagy by confocal microscopy. The
assessment of apoptosis inductionwas evaluated by TUNEL labeling
after 48 h exposure, a time usually necessary but sufﬁcient to see
DNA nuclear breakdown. Positive control was obtained after DNAse
treatment of the cells for 1 h prior toTUNEL labeling. Apoptotic cells
were almost absent in cultures challenged with a-MWCNTs as it
was in control untreated cells. Conversely, a signiﬁcantly increased
but limited number of cells, barely superior to that observed in
control untreated cultures was observed, as illustrated in Fig. 2a
Fig. 1. Cell attachment (a, b), cell viability by Trypan blue exclusion (c), LDH release (d) in primary microglial cultures treated with MWCNTs, a-MWCNTs and DWCNTs compared to
untreated control cultures after 24 and 48 h treatment. (* and ** indicate p < .05 and p < .01 vs respective CTRL).
Fig. 2. a) TUNEL labeling at 48 h in primary microglial cells exposed to CNTs. Positive control was obtained by DNAse treatment of the cells. Black arrows point to apoptotic nuclei
(pink labeling). In positive control cells, all nuclei are positive for TUNEL labeling. b) LC3 labeling at 48 h in primary microglial cells exposed to CNTs. Positive control was obtained
after 24 h serum starvation of the cells. White arrows point to LC3 positive, potential autophagosome formation and therefore autophagic cells (green labeling). c) Quantitative
and quantiﬁed in Fig. 2c, when cells were exposed to MWCNTs and
DWCNTs. Moreover, in order to rule out another possible cause of
cell death, we performed a confocal microscopy analysis of LC3
labeling for the assessment of autophagy (Fig. 2b). To this purpose,
control untreated cells, 24 h serum starved positive control cells
and CNT exposed cells were labeled at 48 h. Confocal microscopic
analysis evidenced the presence of cells positive for the autopha-
gosome marker LC3 and therefore potentially undergoing auto-
phagy, in the cultures exposed to a-MWCNTs and DWCNTs. To
further document such a tendency, we performed a LC3 Western
blot analysis of the cells with or without lysosomal protease in-
hibitors (LPI) pre-treatment; LPI pretreatment enhanced LC3 la-
beling in cells undergoing autophagy (Fig. 2d and e). This approach
allowed us to conﬁrm that some cells underwent autophagy in a
signiﬁcant way when treated with DWCNTs, but also, to a minor
extent, when treatedwith a-MWCNTs. Quantitative analysis of cells
undergoing apoptosis (Fig. 2c) showed that the number of
apoptotic cells exposed to MWCNTs and DWCNTs was signiﬁcantly
higher than control and that the number of cells exposed to
DWCNTs was signiﬁcantly higher than that one of cells exposed to
a-MWCNTs. Quantitative analysis of cells undergoing autophagy
(Fig. 2e) showed a signiﬁcant increase vs control of autophagic cells
in cells exposed to DWCNTs (p< 0.01) and to a-MWCNTs (p< 0.05).
3.3. Nitric oxide (NO) production and inducible nitric oxide
synthase (iNOS) expression
NO production by microglial cell exposed to MWCNTs, a-
MWCNTs or DWCNTs for 24 h is illustrated in Fig. 3a. NO production
was highly signiﬁcantly (p< .01) induced in a-MWCNT treated cell
culture: 15.96 mM for a-MWCNTs vs 7.82 mM for controls corre-
sponding to a two-fold increase in nitrite release (p< .01). MWCNT
treatment also resulted in a signiﬁcant NO production (p< .05), but
to a minor extent as compared with a-MWCNT: 1.6 fold increase
(Fig. 3a).
To further investigate NO production, we analyzed inducible-
NOS (iNOS) expression, by Western blot analysis, in microglial
cells treated with MWCNTs, a-MWCNTs and DWCNTs for 24 h.
Results reported in Fig. 3b, demonstrated that iNOS was signiﬁ-
cantly over expressed (2.67 fold increase vs untreated control) only
in a-MWCNT treated cell cultures (Fig. 3b and c).
3.4. Effects of CNTs on cytokines release
The release of the pro-inﬂammatory cytokines TNF-a and IL-b,
as well as of the anti-inﬂammatory cytokines IL-10 and TGF-b1
from cells exposed to the different CNT samples is shown in Fig. 4.
A signiﬁcant (p< .01) increase in the pro-inﬂammatory cyto-
kines release was detected when cells were exposed to MWCNTs or
to a-MWCNTs for 24 h; DWCNTs did not increased pro-
inﬂammatory cytokines release at 24 h.
After 48 h exposure, even though a signiﬁcantly reduced
amount of the pro-inﬂammatory cytokines was observed in the
supernatants of cell cultures exposed to a-MWCNTs, the cytokine
level was still signiﬁcantly augmented when compared to controls
also in cells exposed to MWCNTs. Conversely, the anti-
inﬂammatory cytokine release, while not increased at 24 h expo-
sure in any of the CNT exposure conditions, was signiﬁcantly
increased in the supernatants of the cell cultures at 48 h exposure
for a-MWCNTs and DWCNTs.
3.5. Effects of CNTs on mature nerve growth factor (mNGF) release
The 118e120 amino acid-long C-terminal peptide produced by
the proteolytic cleavage of the precursor proNGF, is the mature and
neurotrophic form of the NGF. The analysis of mNGF production by
primary culture microglial cells exposed to CNTs at 60 mg/mL con-
centration showed that only a-MWCNTs were able to induce the
release of this neurotrophic factor starting at 24 h and dramatically
increasing after 48 h exposure (Fig. 5).
analysis of apoptotic cells. d)Western blot analysis of LC3-I and LC3-II (nonlipidated and lipidated forms, respectively) at 48 h in primary microglial cells exposed to CNT in presence
(þ) or absence ($) of lysosomal protease inhibitors (LPI). e) Quantitative analysis of LC3-II expression.
(*p < .05 vs CTRL; ** p < .01 vs CTRL; # p < .05 vs trated). (A colour version of this ﬁgure can be viewed online.)
Fig. 3. a) NO production in primary microglial cultures treated with MWCNTs, a-
MWCNTs and DWCNTs compared to untreated control cultures after 24 h treatment (*
p < .05 and ** p < .01 vs CTRL). b, c)Western blot analysis and densitometric analysis of
iNOS expression in primary microglial cultures treated with MWCNTs, a-MWCNTs and
DWCNTs compared to untreated control cultures after 24 h treatment (** p < .01 vs
CTRL).
3.6. Effects of CNTs on extracellular glutamate release and
intracellular glutamate
Glutammate is a neurotoxic molecule produced by microglia
and released extracellularly when these cells are activated by
aggressive stimuli. It is re-up-taken inside the cell as soon as its
toxic action is no more required. This is why it is assessed only at
24 h exposure. Extracellular and intracellular glutamate levels
measured in microglial cell cultures treated with 60 mg/mL
DWCNTs, MWCNTs or a-MWCNTs for 24 h are illustrated in Fig. 6a.
The extracellular glutamate concentration measured in the me-
dium signiﬁcantly increased after 24 h of treatment with a-
MWCNTs and DWCNTs, while no effect was observed with
MWCNTs. Conversely, onlymicroglia exposed to DWCNTs showed a
signiﬁcant reduction of the intracellular glutamate concentration.
No effects on microglia glutamate intracellular level was noticed
when the cells were challenged both with a-MWCNTs and
MWCNTs (Fig. 6).
3.7. Effects of DWCNTs on glutamate transporters GLT-1 and GLAST
To further investigate why only cells exposed to DWCNTs
showed reduced intracellular glutamate levels, we investigated by
Western blot analysis the GLAST and GLT-1 glutamate transporters.
GLAST and GLT-1 transporters have the function to transport
glutamate from outside to inside the cell compartments, and not
vice versa [36]. Their function is affected by the action of biological
Fig. 4. TNF-a, IL-1b, IL-10 and TGF-b1 released by microglia cells exposed to MWCNTs, a-MWCNTs, DWCNTs for 24 h and 48 h (** e !!: p < .01 vs CTRL 24 and 48 h respectively; ##:
p< .01 vs treated).
Fig. 5. mNGF released by microglia cells exposed to MWCNTs, a-MWCNTs, DWCNTs
for 24 h or 48 h (###: p < .001 24 h treated vs 48 h treated).
Fig. 6. Extracellular and intracellular glutamate levels measured in microglial cell
cultures treated with 60 mg/mL DWCNTs, MWCNTs, a-MWCNTs and DWCNTs for 24 h (*
and ** indicate p < .05 and p < .01 vs CTRL).
oxidants. The expression of both GLAST and GLT-1 (Fig. 7) was
signiﬁcantly reduced in microglia treated with DWCNTs at 60 mg/
mL for 24 h (p< .01 versus control), likely due the previously
demonstrated oxidant capacity of DWCNTs [33].
3.8. Morphological changes after CNTs exposure
We analyzedmicroglial cell morphology by confocal microscopy
after immunolabeling for tubulin network (Fig. 8a). In control cul-
tures, where cells are not exposed to CNTs, both bipolar/rod-shaped
microglial cells and amoeboid microglial cells could be observed
both at 24 h and 48 h. When exposed to MWCNTs, microglial cells
tended towards the amoeboid shape, as opposed to cells exposed to
a-MWCNTs, as most of them were found to be bipolar/rod-shaped.
DWCNT exposure conducted to an intermediate phenotype
where both bipolar/rod-shaped and amoeboid cells could be
observed. These morphological changes occurred already after 24 h
and remained unchanged after 48 h exposure.
3.9. Determination of M1/M2 transition
Because of the observed results on the cytokine release showing
a transition, at 48 h, from the pro-inﬂammatory ”M100 to the anti-
inﬂammatory ”M200 phenotype in cells exposed to CNTs, we
aimed to verify whether a morphological change of the cell shape
was also detectable. In this set of experiments, ﬁrst of all cells were
labeled for CD11b (Fig. 8b, green), the classical microglial marker
[37] and then for CD206 (Fig. 8b, red), the mannose receptor, a
classical M2 marker. While control and treated cells were all CD11b
positive, demonstrating that all cells present in the cultures were
microglial cells, the CD206þM2 phenotype was highly signiﬁcantly
expressed at 48 h in cells exposed to a-MWCNTs and, even though
at a minor extent, in DWCNTs. MWCNTs did not signiﬁcantly differ
from controls (Fig. 8c). Besides, always after 48 h exposure, the rod-
shaped morphology, already observed with tubulin labeling, was
much more evident in cells exposed to a-MWCNTs and DWCNTs, as
opposed to MWCNTs exposed cells.
4. Discussion
Microglia cells from rat brain cortex were challenged with
pristine annealed MWCNTs (a-MWCNTs) with electro-conductive
properties, in order to investigate whether intrinsic electrical
properties of engineered carbon-based nanoparticles could impact
and/or modulate the function of these cells. As controls we used
two CNT samples: pristine not annealed MWCNTs (MWCNTs), and
redox-active DWCNTs (DWCNTs) [1,2,33]. Electro-conductive a-
MWCNTs were observed not to be cytotoxic, not inducing cell ne-
crosis or apoptosis but only decreasing cell viability in a small
number of cells and inducing a slight increase of autophagic cells.
Conversely, MWCNTs signiﬁcantly decreased cell viability as early
as after 24 h and up to 48 h and induced an increased, even though
limited, number of apoptotic cells. DWCNTs barely reduced cell
viability but signiﬁcantly increased the number of autophagic
cells.These ﬁndings are consistent with our previous results, ob-
tained in human macrophage cells, whose viability was not
signiﬁcantly affected after 24 h exposure to a-MWCNTs, while
exposure to MWCNTs resulted slightly more cytotoxic towards
these cells [1]. The higher cytotoxic potential of pristine MWCNTs,
not puriﬁed by annealing, as compared to a-MWCNTs, can be
ascribed to their higher biological reactivity due to the presence of
surface chemical functionalities that make themmore reactivewith
the chemical species present in the biological environment and the
cell components. The highly signiﬁcant increase in autophagy
induced by DWCNTs is also consistent with our previous results,
showing an increase of autophagic cells in rat colon carcinoma cells,
probably due to the redox activity of these CNTs [33]. The slight
increase in the number of autophagic cells induced by a-MWCNTs,
even though at a lower extent than that one induced by DWCNTs,
could be considered a consequence of the highly stimulating ac-
tivity of these CNTs on microglia that eliminate, through a physi-
ological process, stressed cells.
Data on the neuro-toxicological proﬁle of CNTs are limited and
inconsistent [9]. In a study assessing the impact of CNTs on primary
mixed neuro-glial cell cultures of the peripheral and central ner-
vous system, an higher cytotoxicity on glial cells than on neurons
has been reported [17]. The toxicity of Pluronic F127-coated
MWCNTs against neuroblastoma cells was shown to be depen-
dent on the concentration, incubation time, material purity and the
presence of carboxyl groups on the acid-treated CNT surface [12].
MWCNTs with high iron catalyst impurity content were demon-
strated to alter cell viability of pheochromocytoma cells [13]. More
recently it has been demonstrated that functionalized MWCNTs,
were not toxic towards microglial cells originating from frontal
cortex but only to microglia from striatum. The authors hypothe-
sized that the brain region-speciﬁc sensitivity was related to the
higher number of microglial cells in this brain area [11]. Our data,
showing that electro-conductive a-MWCNTs were not cytotoxic
and did not affect brain cortex microglia viability, are in agreement
with the above mentioned study. On the contrary, and unlike what
Fig. 7. Western blot analysis of GLAST and GLT-1 glutamate transporters and related quantiﬁcation in microglial cell cultures treated with 60 mg/mL DWCNTs for 24 h (**: p < .01 vs
CTRL).
Fig. 8. a) Tubulin labeling at 24 h (upper lane) and 48 h (lower lane) in primary microglial cells exposed to CNTs. Bar represents 100 mmb) CD11b (green) and CD206 (red) labeling at
24 h (upper lane) and 48 h (lower lane) in primary microglial cells exposed to CNTs. Bar represents 50 mm c) Quantitative analysis of M2 phenotype (see methods). (A colour version
of this ﬁgure can be viewed online.)
observed by Bussy and co-workers, our MWCNTs signiﬁcantly
decreased brain cortex microglia viability. This could be attributed
to the high biological reactivity of these CNTs due to the high
number of reactive chemical sites on their surface. Conversely, the
above mentioned study was performed with functionalized
MWCNTs with different surface properties than our pristine
MWCNTs. So, our ﬁndings strengthen once more the assumption
that CNT cytotoxicity depends equally on the peculiar characteris-
tics (electrical properties, length, diameter, state of aggregation,
grade of dispersion, functionalization, etc.) of the CNT sample
tested and on the cell type used, its sensitivity, phenotype and
function.
Finally, in order to further evaluate the neurotoxic activity of our
CNTs, we investigated the effects of CNT exposure on extracellular/
intracellular glutamate content, a molecule secreted by activated
microglia that induces neuronal toxicity. Only a-MWCNTs and
DWCNTs induced a signiﬁcant increase in extracellular glutamate
level. Conversely, only microglia exposed to DWCNTs showed a
signiﬁcant decrease in intracellular glutamate levels, and a
concomitant reduced expression of GLAST and GLT-1 glutamate
transporters. Several studies have demonstrated that activated
microglia release glutamate in quantities sufﬁcient enough to
induce neuronal death via over-activation of ionotropic glutamate
receptors [38,39]. Excessive extracellular glutamate levels are
rapidly removed from the extracellular ﬂuid surrounding its re-
ceptors by cellular re-uptake [40]. This is accomplished by GLAST
and GLT-1 glutamate transporters in the plasma membranes of
both astrocytes and neurones [41]. GLAST and GLT-1 number and
function is affected by the action of biological oxidants resulting in
reduced glutamate intracellular re-uptake [42]. Thus, it is likely that
the observed decrease in intracellular glutamate in microglia
exposed to redox-active DWCNTswas due to the oxidant capacity of
these CNTs. On the contrary, the normal intracellular glutamate
level detected in cells exposed to a-MWCNTs and MWCNTs could
be explained by the fast intracellular re-uptake of glutamate made
possible by the functioning GLAST and GLT-1 glutamate trans-
porters. Conﬂicting results have been reported on the pro-
inﬂammatory effects of CNTs on microglia cells. Pristine MWCNTs
have been shown to be internalized by these cells, to severely
impact cell migration and phagocytic capacity and to induce cell
death by apoptosis [8]; non-functionalized pristine MWCNTs were
shown to be up-taken by microglia without being cytotoxic [16].
Different types of chemically functionalized MWCNTs were re-
ported to be up-taken by microglia and to induce NO release from
these cells [11]. We showed that electro-conductive a-MWCNTs,
and at a minor extent MWCNTs, possess a signiﬁcantly high pro-
inﬂammatory activity increasing the release of nitrites, inducible
nitric oxide synthase (iNOS) and of the main pro-inﬂammatory
cytokines (IL-1b, TNF-a) after 24 h exposure. This activity was
shown to signiﬁcantly decrease at 48 h while a shift to a signiﬁcant
increase of anti-inﬂammatory cytokines (IL-10 and TGF-b1)
occurred at that time, especially in cells exposed to a-MWCNTs.
DWCNTs did not increase pro-inﬂammatory cytokine levels at 24 h
but induced a signiﬁcant increase of anti-inﬂammatory cytokines at
48 h. In addition, the neurotrophic factor mNGF was shown to be
abundantly released only when microglia was exposed to a-
MWCNTs after 48 h exposure. The neurotrophin nerve growth
factor (NGF) is a well known regulator of differentiation, plasticity,
and phenotype of sensory and sympathetic neurons during the
entire lifespan [43]. Based on recent studies, NGF seems to modu-
late inﬂammatory cytokine production by exerting an anti-
inﬂammatory effect, mediated through its receptor TrkA, reducing
inﬂammatory cytokine production (IL-1b, TNF-a, IL-6, and IL-8)
while inducing the release of anti-inﬂammatory mediators (IL-10
and IL-1 receptor antagonist) [44]. Thus, a-MWCNTs were able to
signiﬁcantly stimulate pro-inﬂammatory activity in microglia at
24 h. Then, the pro-inﬂammatory cytokines induced the release of
high levels of mNGF that in turn signiﬁcantly down-regulated pro-
inﬂammatory cytokine release increasing at the same time anti-
inﬂammatory activity at 48 h in these cells.
Although cell exposure was not prolonged beyond 48 h, to
prevent too long exposure from damaging cells and altering the
results, we were able to observe in this short time frame that a-
MWCNTs changed microglia phenotype from “M1”to “M2”
phenotype, not being cytotoxic.
The study of cell morphology, with immune-labeling of the
tubulin network, and of the cell phenotype after immune-labeling
with CD11b, the classical microglial marker and CD206, the classical
M2marker [21,37], conﬁrmed that all the cells were CD11b positive
microglial cells and that the CD206-positive “M2” phenotype was
particularly expressed after 48 h in cells exposed to electro-
conductive a-MWCNTs. The morphology of microglia exposed to
MWCNTs, showed a tendency towards the amoeboid shape, as
opposed to cells exposed to a-MWCNTs, as most of them were
found to be bipolar/rod-shaped. DWCNT exposure brought to an
intermediate morphological pattern where both bipolar/rod-
shaped and amoeboid cells could be observed. These morpholog-
ical changes occurred already after 24 h and remained unchanged
after 48 h exposure. The morphological changes observed in
microglia are the expression of their functional activities [45].
Recently, it has been shown that another microglia morphological
feature exists: bipolar/rod-shaped microglia, which transiently
form trains of cells aligned end-to-end close to a damaged brain site
[45e51]. Recently, it has been shown the potential neuro-protective
role of bipolar/rod-shaped microglia. Indeed, the spatial arrange-
ment of bipolar/rod-shaped microglia seems to play a role in the
reorganization and remodeling of neuronal circuitry following CNS
injuries [52]. Our ﬁndings, showing the transition towards bipolar/
rod-shaped microglia after a-MWCNT cell exposure, rather than a
switch towards the amoeboid shape, as observed after MWCNTs
exposure, and the induction of the release of anti-inﬂammatory
cytokines and neurotrophic factors after 48 h exposure, seem
extremely important to support the capacity of electro-conductive
a-MWCNTs to modulate brain cells behavior and functions towards
neuroprotective effects. These ﬁndings show that a transition be-
tween the two activation states can occur when stimulating
microglia with a-MWCNTs, solid-state nanomaterials with pro-
nounced electrical properties, and that the anti-inﬂammatory state
starts later than the pro-inﬂammatory one.
So far, to our knowledge, there are no data in the literature about
the capacity of CNTs to initially activate microglia towards pro-
inﬂammatory activity and later to stimulate the release of the
neurotrophic factor mNGF leading to the anti-inﬂammatory ca-
pacity of these cells, thus changing cell phenotype and function. It is
noteworthy that for the ﬁrst time it is shown the role played by
electro-conductive CNTs in modulating brain cells behavior. Our
previous studies highlighted the existence of electro-chemical in-
teractions taking place between cell membranes and electro-
conductive MWCNTs.We demonstrated the ability of elettro-
conductive a-MWCNTs to signiﬁcantly affect, in a very short time,
some cell functions strictly dependent on electro-chemical mech-
anisms (the mitochondrial membrane polarity, the intracellular pH
and the reorganization of cytoskeleton actin ﬁlaments). This ca-
pacity was attributed to the rapidly occurring interaction between
cell membranes and electro-conductive MWCNTs probably due to
the generation of low intensity electrical (ionic) currents occurring
in the culture medium exposed to these CNTs [1,2]. CNTs have
recently been regarded as interesting candidates for highly selec-
tive and permeable solid-state ion channels, mimicking biological
ion channels, due to their unique structure. Recent data,
demonstrating the electrophoretic transport of ions through CNTs
[53] support and strengthen our hypothesis that electrochemical
interactions, due to the generation of ionic currents, could take
place between cell membranes and electro-conductive CNTs. Taken
together, our results show, for the ﬁrst time, that electro-
conductive MWCNTs can change microglia phenotype and func-
tion, without been cytotoxic. These ﬁndings could be extremely
important in view of the upcoming exploitation of CNTs in nerve
tissue engineering since the peculiar effects of some kinds of CNTs
on microglia, an important brain cell population that possesses a
key role in brain cell network homeostasis and functioning, must be
taken into consideration.
5. Conclusions
We showed that metallic MWCNTs impact microglia cell
phenotype and function and that transition of microglia fromM1 to
M2 phenotype can be achieved by stimulating cells with CNTs
possessing electro-conductive properties. To our knowledge, yet
data are lacking on the capabilities of CNTs to modulate microglia
function and phenotype without being cytotoxic. Microglia play a
key role in the regulation of CNS homeostasis. The dysregulation of
the microglial activity is involved in the pathogenesis of neurode-
generative and neuroinﬂammatory diseases; in these latest, where
neuroinﬂammation is a prominent feature and a potential
contributor to the diseases, the alternativelyM2 activatedmicroglia
would be beneﬁcial in resolving the pathology [28]. Therefore, the
potential of a substance to modulate microglial responses could be
an attractive therapeutic target, especially in those pathological
conditions where classical drugs are ineffective. The intrinsic
electrical properties of CNTs should be exploited in a near future to
modulate phenotype and functions of these polyhedral brain cells.
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